Agilent Technologies, Inc. (A) - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Agilent Technologies, Inc. (A) - Medical Equipment - Deals and Alliances Profile

Agilent Technologies, Inc. (A) - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Agilent Technologies, Inc. (A) - Medical Equipment - Deals and Alliances Profile
Published Oct 18, 2016
137 pages — Published Oct 18, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Agilent Technologies, Inc. (Agilent) is a provider of instruments, reagents, software, services and consumables to diagnostics, life sciences and applied chemical markets for comprehensive laboratory workflow. The company offers its products to biotechnology, pharmaceutical, CRO and CMO, chemical and energy, environmental and forensics, and food industries. Agilent markets its products through direct sales force, distributors, manufacturers representatives, resellers and e-commerce. The company conducts research and development (R&D) activities through Agilent Technologies Research Laboratories.

Agilent Technologies, Inc. (A) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical Equipment eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal

  
Source:
Document ID
GDME3859D
Country
Industry
Ticker
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents26
  List of Tables52
  List of Figures71
Agilent Technologies, Inc., Medical Equipment, Deals By Year, 2010 to YTD 201672
Agilent Technologies, Inc., Medical Equipment Deals By Type, 2010 to YTD 201691
Agilent Technologies, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016101
Agilent Technologies, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016111
Agilent Technologies, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016125
Agilent Technologies, Inc., Medical Equipment, Deal Details1783
  Asset Purchase171
    Dako To Acquire Intellectual Property Rights From System Dynamics171
  Venture Financing181
    Seahorse Bioscience Raises US$11 Million In Series E Financing182
    Seahorse Bioscience Secures US$5 Million In Series D Financing202
  Private Equity221
    Linden Acquires Hycor Biomedical From Agilent Technologies221
  Partnerships231
    Agilent Technologies Enters Into Licensing Agreement With SRI International For BioCyc Pathway Database Collection231
    Seahorse Bioscience Enters Into Licensing Agreement With Pioneer Valley Life Sciences241
    Dako Enters Into Licensing Agreement With Van Andel Research Institute For Cancer Diagnostic Tool251
    Agilent Technologies Enters Into Licensing Agreement With Kreatech Diagnostics261
    Agilent Technologies Enters into Agreement with Burning Rock Biotech271
    Agilent Technologies Enters into Co-Marketing Agreement with Applied Spectral Imaging281
    Agilent Technologies Enters into Agreement with Eurofins Genomics291
    Agilent Technologies Enters into Agreement with 10X Genomics301
    Agilent Technologies Enters into Agreement with Thermo Fisher Scientific311
    Merck and Pfizer Enters into Agreement with Dako322
    Dako Enters into Co-Development Agreement with Amgen for Companion Diagnostic341
    Dako Enters into Development Agreement with ONO PHARMA for Opdivo351
    Agilent Extends Co-Marketing Agreement with MRM Proteomics361
    Dako Enters into Agreement with Merck for Companion Diagnostic Test371
    Agilent Technologies Enters Into Agreement With Cell Line Genetics For Regenerative Medicine381
    Dako Enters Into Co-Development Agreement With Amgen For Molecular Diagnostic Test391
    Dako And Omnyx Enter Into Co-Marketing Agreement For Breast Cancer Diagnostics401
    Agilent Technologies Enters Into Agreement With SomaLogic For SOMAscan Proteomic Assay411
    Agilent Enters Into Research Agreement With Chungnam National University421
    Agilent Technologies Enters Into Co-Development Agreement With Florida International University431
    Agilent Technologies Enters Into Co-Development Agreement With Sera Prognostics441
    Dako Enters Into Agreement With Pfizer For Companion Diagnostics451
    Agilent Technologies Enters Into Research Agreement With Ameritox461
    Dako Enters Into Agreement With Eli Lilly To Develop Companion Diagnostic Tests471
    Advion Enters Into Technology Integration Agreement With Agilent Technologies481
    Agilent Technologies Enters Into Co-Marketing Agreement With Molecular Discovery491
    Agilent Technologies Enters Into Co-Marketing Agreement With MRM Proteomics501
    Agilent Enters Into Co-Development Agreement With Gachon University For Biomarkers511
    Dako Enters Into Co-Development Agreement With Amgen521
    Agilent Technologies Enters Into Co-Development Agreement With Integrated Diagnostics531
    Dako Enters Into Co-Development Agreement With Amgen541
    Dako Enters Into Co-Development Agreement With Bristol-Myers551
    Agilent Technologies Enters Into Co-Marketing Agreement With Bridge12 Technologies561
    Dako Denmark Enters Into Co-Development Agreement With Epitomics571
    Nikon Instruments Enters Into Distribution Agreement With Agilent Technologies581
    Dako Enters Into Distribution Agreement With BioPorto591
    Agilent Technologies Enters Into Collaboration With Wyss Institute for Biologically Inspired Engineering at Harvard University602
    Dako Enters Into Agreement With Quintiles Transnational621
    Royal Philips Electronics Signs An Agreement With Dako631
    Dako Enters Into An Agreement With Omnyx641
    Agilent Technologies Enters Into Co-Marketing Agreement With Integrated DNA Technologies651
    BIOCIUS Life Sciences Enters Into Distribution Agreement With Wako Pure Chemical Industries661
    AstraZeneca Enters Into Co-Development Agreement With Dako Denmark671
    Agilent Technologies Enters Into Co-Marketing Agreement Covaris681
    Population Genetics Enters Into Licensing Agreement With Agilent Technologies For VeriTag Technology691
    Eppendorf Enters Into Licensing Agreement With Agilent Technologies701
  Debt Offering711
    Agilent Technologies Raises USD300 Million in Public Offering of Notes Due 2026712
    Agilent Technologies Completes Public Offering Of Notes Due 2023 For US$600 Million732
    Agilent Technologies Completes Public Offering Of Notes Due 2022 For US$400 Million752
    Agilent Technologies Completes Public Offering Of 2.5% Senior Notes For US$250 Million772
    Agilent Technologies Completes Public Offering Of 5% Senior Notes For US$500 Million792
  Asset Transactions811
    BioReliance To Acquire Rights To Big Blue Colonies and Cell Lines From Agilent Technologies812
    Persistent Systems Completes Acquisition Of Software Business From Agilent Technologies831
    Bruker Completes Acquisition Of Three Varian Product Lines From Agilent Technologies842
  Acquisition861
    Agilent Technologies Acquires 48% Stake in Lasergen for USD80 Million861
    Agilent Technologies Acquires Seahorse Bioscience for USD235 Million871
    Agilent to Acquire Cartagenia881
    Agilent Technologies To Acquire ABC Instrumentacion Analitica891
    Leica Biosystems Completes Acquisition Of Aperio Technologies902
    Agilent Technologies Completes Acquisition Of Dako From EQT For US$2.2 Billion922
    Agilent Technologies Completes Acquisition Of BioSystem Development941
    Agilent Technologies Acquires P.V.R.951
    Agilent Technologies Acquires Lab901962
    Agilent Technologies Completes Acquisition Of Varian982
Agilent Technologies, Inc. - Key Competitors1001
Key Employees1012
Locations And Subsidiaries1034
  Head Office1031
  Other Locations &Subsidiaries1034
Recent Developments1071
Strategy And Business Planning1071
Dec 08, 2015: Protea Announces Biopharm Industry Collaboration1071
Sep 23, 2015: Agilent Technologies Announces Opening of Life Science Research Center at Carleton University1081
May 19, 2015: Agilent Technologies Advances Solutions to Drive Better Outcomes for Customers1091
Financial Announcements1101
Aug 17, 2016: Agilent Technologies Reports Third-Quarter 2016 Results1101
May 16, 2016: Agilent Technologies Reports Second-Quarter 2016 Results1111
Feb 16, 2016: Agilent Technologies Reports First-Quarter 2016 Results1121
Nov 16, 2015: Agilent Technologies Reports Fourth-Quarter 2015 Results1131
Aug 17, 2015: Agilent Technologies Reports Third-Quarter 2015 Results1141
May 18, 2015: Agilent Technologies Reports Second-Quarter 2015 Results1151
Feb 17, 2015: Agilent Technologies Reports First-Quarter 2015 Results1161
Corporate Communications1171
Jan 06, 2016: Agilent Technologies Names Michael Tang Senior Vice President, General Counsel and Secretary1171
Nov 02, 2015: A. Barry Rand Retires from Agilent Technologies Board of Directors1181
Sep 15, 2015: Sue H. Rataj, Former Energy Executive, to Join Agilent Technologies Board of Directors1191
Mar 18, 2015: Agilent Technologies Announces New CEO Mike McMullen1201
Mar 18, 2015: Daniel K. Podolsky, M.D., of University of Texas Southwestern Medical Center, to Join Agilent Technologies Board of Directors1211
Legal and Regulatory1221
Jan 06, 2016: ENZO Biochem Reaches $9 Million Patent Infringement Settlement with Agilent Technologies1221
Apr 22, 2015: Agilent Technologies Announces Resolution to U.S. FDA Warning Letter for Dako Denmark1231
Product News1241
Feb 26, 2015: Agilent Technologies Introduces ClearSeq to Advance Clinical Cancer Research1241
Jan 27, 2015: Agilent Gets Chinese Approval For SureScan Dx Microarray Scanner1251
Product Approvals1261
Jan 27, 2015: Agilent Gets Chinese Approval For SureScan Dx Microarray Scanner1261
Other Significant Developments1271
Jul 28, 2016: Agilent Technologies Array CGH Platform Assures Quality of Cancer Cell Lines Used in Biomedical Research1271
Mar 14, 2016: Agilent Publishes Overview of Best Practices for Breast Cancer Diagnosis1281
Feb 11, 2016: Agilent Technologies Announces Early Access to Custom guideRNA for Functional Genomics1291
Feb 11, 2016: TRADE NEWS: Agilent Technologies Announces Early Access to Custom guideRNA for Functional Genomics1301
Jan 27, 2016: Agilent Technologies Wins Award for Innovation in Liquid Chromatography1311
Jan 19, 2016: Agilent Technologies Extends Agreement with PerkinElmer on Bioanalyzer Chips1321
May 28, 2015: Agilent Technologies to Focus on "Powerful Partnerships, Inspiring Results" at ASMS 20151331
Mar 17, 2015: Agilent Technologies Receives Innovation Award for Multiple Heart-Cutting Solution1341
Mar 09, 2015: Agilent Technologies Announces Major University Client for Informatics Software1351
Jan 16, 2015: Agilent Technologies Names Alacris Theranostics as Certified Provider of Target Enrichment Services1361
Appendix1371
  Methodology1371
  About GlobalData1371
  Contact Us1371
  Disclaimer1371

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Agilent Technologies, Inc. (A) - Medical Equipment - Deals and Alliances Profile" Oct 18, 2016. Alacra Store. Nov 15, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Agilent-Technologies-Inc-A-Medical-Equipment-Deals-and-Alliances-Profile-2148-1300>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Agilent Technologies, Inc. (A) - Medical Equipment - Deals and Alliances Profile Oct 18, 2016. New York, NY: Alacra Store. Retrieved Nov 15, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Agilent-Technologies-Inc-A-Medical-Equipment-Deals-and-Alliances-Profile-2148-1300>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research